Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04797403 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Implementation of Multifaceted Patient-Centered Treatment Strategies for Intensive Blood Pressure Control in Minimize Cognitive Decline

Study acronym: IMPACTS-MIND
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 31 days later Aug 2026 → Oct 2026
See other at-risk trials from Tulane University

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Aug 2026 to Oct 2026
    • Eligibility criteria expanded, about 15 words
    • Secondary endpoints: details revised at 2 of 5 entries
    • Study description revised
  2. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 1260 to confirmed 1306
    • Primary and study completion dates: Jul 2026 to Aug 2026
    • Site details revised
    v6
  3. Phase: Phase 3 to Not applicablev5 Show 4 more changesShow less
    • Primary and study completion dates: Jul 2025 to Jul 2026
    • Enrollment target: 920 to 1260
    • Secondary endpoints: details revised at 5 of 5 entries
    • Study description revised
  4. 2 versions Re-verified since May 2, 2022, no change to tracked fieldsv3-v4
  5. Start date: Aug 1, 2020 to Oct 22, 2019v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Tulane University
47 trials monitored
See 8 trials at risk
Hypertension
1,925 trials monitored
See 99 trials at risk
The study will test a multifaceted strategy for implementing an intensive blood pressure intervention protocol targeting systolic BP \<120 mmHg on cognitive decline in racial minority and low-income hypertensive patients in primary care. The proposed study will generate urgently needed data on effective, adoptable, and equitable intervention strategies to reduce blood pressure-related cognitive decline in low- income and minority populations. If proven effective, the implementation strategy for intensive blood pressure reduction could be adapted and scaled up in diverse primary care settings to prevent cognitive decline and clinical dementia.
Trial Details
NCT Number NCT04797403
Lead Sponsor Tulane University
Collaborators: Wake Forest University, National Institute on Aging (NIA)
Conditions
(from sponsor)		 Hypertension, Cognitive Decline
Related terms Cognitive Dysfunction, Hypertension
Enrollment 1,306 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov